Pharma Tech Outlook: Specials Magazine

Pharmaceutical equipment engineering has always operated between evolving industry demands and the structural limitations of what most equipment suppliers are set up to deliver. Those demands are now rising far beyond standard specifications. Biotech companies exploring next-generation therapies, CDMOs juggling high-mix, low-volume production, and formulation teams running multiple development cycles depend on equipment that can keep pace in both form and function. In those environments, even systems labelled as “customised” often fall short of what’s truly needed. That’s because most customisations rely on a predefined architecture. While suppliers may offer configurable options, the starting point remains a fixed platform, designed for flexibility rather than reinvention. This can quickly become a bottleneck, particularly for companies navigating scientific breakthroughs. When process requirements evolve, the equipment must evolve with them. That’s where Persep finds its edge. Based in Poland, Persep is part of a next-generation equipment manufacturer that doesn’t begin with a catalogue of equipment. Instead, each system is made to order, engineered from the ground up to match the exact needs of the client’s process. Whether a sterile fill-finish line is being developed for a first-in-human trial or a scalable bioprocess system for a personalised therapy, Persep treats every project as a unique challenge rather than a product adaptation. “Our starting point isn’t a brochure. It’s the process flow diagram,” says Paweł Mierzejewski, co-founder and CEO. “If a client’s formulation team has created something unique, our job is to engineer the equipment that can bring that idea into full-scale production.” This is engineering with intent. Every dimension, integration point and process parameter is considered in the context of the client’s facility, product profile, and production cadence. Its systems support the full lifecycle of pharmaceutical innovation from the earliest lab-scale validation to full-scale GMP manufacturing. This approach brings a level of customisation rarely seen in traditional builds. Engaging directly with process engineers, QA teams and production planners ensures development is aligned with the client’s operational realities. The company’s lean, collaborative structure allows for real-time adjustments to user requirement specifications (URS) as projects evolve, without disrupting timelines or regulatory pathways. At a time when pharmaceutical manufacturing is under pressure to be faster, more adaptive, and more transparent, Persep isn’t just meeting the moment. It’s helping to define what the next generation of pharma equipment design should look like.